MSTR.US Weekly Report · 2026-W37
Opening Summary
MSTR declined sharply this week, down 8.27% from the prior week. While it briefly reached new highs early in the week, the stock subsequently broke key levels and entered a consolidation phase. The latest quarterly report reveals severe losses (EPS -24.45), well below analyst consensus, yet analysts maintain a strong buy rating with a target price of $226.2 implying 72.7% upside. Capital flows show net outflows, reflecting selling pressure. The contradiction between low valuation and deteriorating earnings, coupled with optimistic ratings and capital withdrawal, underscores underlying tensions.
Price Action
From last Friday (Sept 4) at 142.80 to this Friday (Sept 11) at 130.97, the stock posted a weekly decline of -8.27%. Within the week, the high reached 137.89 and the low touched 129.28, showing a daily swing range of approximately 6.6%.
Trading Activity: Average daily volume this week was 178,000 shares, down noticeably from the 60-day average of 223,000 shares, reflecting diminished short-term trading interest. Weekly average turnover was approximately $2.59 billion with a turnover rate of 5.99%, maintaining stable liquidity.
Weekly Pattern: Monday (Sept 8) opened with a gap-up to 137.62 and reached a session high of 139.31; Tuesday (Sept 9) rallied higher then retreated to 132.59; Wednesday (Sept 10) continued testing the weekly low of 126.91; Thursday (Sept 11) bounced to close at 130.97. The week traced a U-shaped pattern—gap-up, topping, selling down, and recovery—suggesting potential support is forming at lower levels.
Valuation and Earnings
Valuation Level
The P/B ratio stands at 1.47, placing it at the 89.37th percentile over the past year—cheaper than approximately 89% of prior trading days, reflecting a historical low. The industry median is 2.27, making MSTR approximately 35% below sector average and ranking 60th out of 254 in the industry.
Earnings vs. Consensus
Latest quarterly results (Q2 2026):
- EPS: -24.45 USD, deteriorating 175% year-over-year; while improved versus Q1’s -38.25, remains deeply negative
- Revenue: $122.4 million, growing 6.88% year-over-year at a moderate pace
- Net Income: -$862 million, worsening 186% year-over-year
- Operating Income: -$833 million, deteriorating 159% year-over-year
Versus consensus: Analyst consensus expects EPS of 70.65, versus actual Q2 EPS of -24.45—a massive miss. Two consecutive quarters of losses indicate deteriorating trends despite sequential improvement, signaling ongoing operational challenges.
Capital Flows and Institutional Views
Fund Flows
Net outflows this week. Distribution by investor class:
- Large investors: Net outflow (inflow 5,084.57 vs. outflow 5,982.30)
- Mid-size investors: Net outflow (inflow 9,079.12 vs. outflow 11,325.21)
- Retail investors: Net inflow (inflow 12,686.98 vs. outflow 11,847.68)
Institutional investors are reducing positions cautiously while retail investors hold relatively firm, reflecting divergent market sentiment.
Analyst Ratings
Among 16 analysts: 13 buy (81%), 1 hold, 2 sell. Current target price is $226.2, implying 72.7% upside from current price of $130.97. However, the latest rating update was September 8, 2026—a lagging signal, as stock price continued declining even after the upgrade.
Weekly News and Market Context
Core Narrative
-
Capital Structure and Risk Management: Management emphasizes that 91% permanent capital strengthens the balance sheet and demonstrates financial resilience.
-
Investment Strategy Shift: The company allocated $176.3 million to preferred shares rather than Bitcoin, and recent Bitcoin purchases are underwater. This signals prioritization of financial stability over cryptocurrency appreciation expectations.
-
Analyst Activity: Canaccord raised the price target on September 8, driving a 2.94% pre-market gap-up; however, the stock failed to sustain this gain and continued declining.
Key News Items (ordered by importance):
- Strategy (MSTR) Says 91% Permanent Capital Makes Its Balance Sheet Safer
- Strategy put $176.3 million into its own preferred stock instead of Bitcoin, with its last BTC purchase already underwater
- Strategy (NASDAQ:MSTR) Shares Gap Up Following Analyst Upgrade
- STOCKS | Strategy Shares Rise 2.94% in Premarket Trading as Canaccord Raises Price Target
- Why Is Strategy Stock Surging on Wednesday?
- Crypto Stocks Rally in Regular Trading, BMNR Up 5%, MSTR Up 4%
- Crypto Stocks Rise in Regular Trading, BMNR Up 4%, MSTR Up 2%
- Midday Market Pulse: Core CPI Tops Estimates as Tech and Crypto Stocks Rally Against the Tide
- MSTR price could hit $124 or $145 soon. It decreased by 6.19% in 24 hours, now at $131.30 with $127.69 support crucial.
- Crypto Stocks Show Mixed Performance, BMNR Up Over 3%
Signal Contradictions and Alignment
Conflicting Signals
-
Depressed Valuation vs. Severe Earnings Deterioration: P/B of 1.47 sits at historical lows (89th percentile), yet the company is drowning in consecutive quarterly losses (Q2 EPS -24.45), far below expectations. The low valuation may reflect market skepticism on earnings recovery rather than a simple oversold opportunity.
-
Strong Analyst Support vs. Active Capital Withdrawal: Thirteen of sixteen analysts rate buy; the target price implies 72.7% upside, representing extreme optimism. Yet this week large and mid-size investors withdrew capital, suggesting analyst ratings lag negative fund signals. Stock price continued falling despite the rating upgrade.
-
Balance Sheet Resilience Claims vs. Operating Deterioration: Management repeatedly emphasizes 91% permanent capital and preferred share investments to shore up financial strength. Conversely, this rhetorical focus on financial fortification mirrors caution about near-term operational prospects. Defensive language on the balance sheet hints at management pessimism on earnings outlook.
Signal Alignment
Price action and fund flows align: weekly stock decline accompanied by net institutional outflows (large and mid-size net sales). This “price down, volume down” consistency signals sustained downward pressure in the near term.
Summary
This week MSTR retreated from earlier highs and consolidated near support levels, yet on reduced trading volume. The surface narrative of low valuation, extreme analyst bullishness, and strong balance sheet rhetoric masks the underlying reality of severe earnings losses and deliberate institutional de-risking. Management’s repeated emphasis on financial safeguards paradoxically betrays caution about operational recovery. In the near term, whether the stock holds the $127.69 support level will prove critical.